Loading clinical trials...
Loading clinical trials...
Safety, Tolerability, and Pharmacokinetic Interactions of Atazanavir and Rifampin in Healthy Volunteers
Conditions
Interventions
Atazanavir
Rifampin
+1 more
Locations
3
United States
Stanford CRS
Palo Alto, California, United States
The Ohio State Univ. AIDS CRS
Columbus, Ohio, United States
Vanderbilt Therapeutics CRS
Nashville, Tennessee, United States
Completion Date
December 1, 2007
Last Updated
November 1, 2021
NCT06627764
NCT06192160
NCT05947890
NCT05989802
NCT06694805
NCT05941052
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions